Case study: The role of mechanistic network models in systems toxicology

Drug Discovery Today

Volumn 19, Issue 2, 2014, Pages 183-192

  Hoeng, Julia ^a   Talikka, Marja ^a   Martin, Florian ^a   Sewer, Alain ^a   Yang, Xiang ^a   Iskandar, Anita ^a   Schlage, Walter K ^a   Peitsch, Manuel C ^a  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CIGARETTE SMOKE;

BIOLOGICAL MODEL; CELL STRESS; CROWDSOURCING; DATA ANALYSIS; DATA PROCESSING; DRUG DEVELOPMENT; DRUG SAFETY; ENVIRONMENTAL IMPACT; EXPOSURE; HUMAN; INFORMATION PROCESSING; LUNG; LUNG LAVAGE; MACROPHAGE ACTIVATION; NONHUMAN; REVIEW; SMOKING CESSATION; SYSTEMS BIOLOGY; TOXICITY TESTING; TOXICOLOGY; XENOBIOTIC METABOLISM; ADVERSE DRUG REACTION; BIOLOGY; METABOLISM; PROCEDURES;

BIOLOGICAL MARKERS; COMPUTATIONAL BIOLOGY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; MODELS, BIOLOGICAL; SYSTEMS BIOLOGY; TOXICOLOGY;

EID: 84895918030     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.07.023     Document Type: Review

References (77)

1. National Research Council Committee on Toxicity Testing Assessment of Environmental Agents Toxicity Testing in the 21st Century: A Vision and a Strategy 2007 N. A. Press
2. D. Krewski et al. New directions in toxicity testing Annu. Rev. Public Health 32 2011 161 178
3. S. Bhattacharya et al. Toxicity testing in the 21 century: defining new risk assessment approaches based on perturbation of intracellular toxicity pathways PLoS ONE 6 2011 e20887
4. D.A. Keller et al. Identification and characterization of adverse effects in 21st century toxicology Toxicol. Sci. 126 2012 291 297
5. C.K. Atterwill, and M.G. Wing In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical development Toxicol. Lett. 127 2002 143 151
6. E. Lee et al. Inferring pathway activity toward precise disease classification PLoS Comput. Biol. 4 2008 e1000217
7. J. Hoeng et al. A network-based approach to quantifying the impact of biologically active substances Drug Discov. Today 17 2012 413 418
8. J. Lamb et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease Sci. Signal. 313 2006 1929
9. F. Iorio et al. Discovery of drug mode of action and drug repositioning from transcriptional responses Proc. Natl. Acad. Sci. U. S. A. 107 2010 14621 14626
10. Y. Xiang et al. Divergence weighted independence graphs for the exploratory analysis of biological expression data J. Health Med. Inform. S2 2011 10.4172/2157-7420 S2-001
11. P. Lecca, and C. Priami Biological network inference for drug discovery Drug Discov. Today 18 2013 256 264
12. D. Marbach et al. Revealing strengths and weaknesses of methods for gene network inference Proc. Natl. Acad. Sci. U. S. A. 107 2010 6286 6291
13. H.-W. Mewes et al. MIPS: a database for genomes and protein sequences Nucleic Acids Res. 30 2002 31 34
14. I. Xenarios et al. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions Nucleic Acids Res. 30 2002 303 305
15. A. Chatr-Aryamontri et al. MINT: the Molecular Interaction Database Nucleic Acids Res. 35 2007 D572 D574
16. H. Hermjakob et al. IntAct: an open source molecular interaction database Nucleic Acids Res. 32 2004 D452 D455
17. D. Gilbert Biomolecular interaction network database Brief Bioinform. 6 2005 194 198
18. K. Venkatesan et al. An empirical framework for binary interactome mapping Nat. Methods 6 2008 83 90
19. C. Lei, and J. Ruan A novel link prediction algorithm for reconstructing protein-protein interaction networks by topological similarity Bioinformatics 29 2013 355 364
20. D.M. Hendrickx et al. Reverse engineering of metabolic networks, a critical assessment Mol. Biosyst. 7 2011 511 520
21. H. Ogata et al. KEGG: Kyoto encyclopedia of genes and genomes Nucleic Acids Res. 27 1999 29 34
22. J. Schellenberger BiGG: a biochemical genetic and genomic knowledgebase of large scale metabolic reconstructions BMC Bioinformatics 11 2010 213
23. S. Hasan et al. Network analysis has diverse roles in drug discovery Drug Discov. Today 17 2012 869 874
24. M.A. YIldIrIm et al. Drug-target network Nat. Biotechnol. 25 2007 1119
25. A.L. Hopkins Network pharmacology: the next paradigm in drug discovery Nat. Chem. Biol. 4 2008 682 690
26. G.D. Bader et al. Pathguide: a pathway resource list Nucleic Acids Res. 34 2006 D504 D506
27. E. Demir et al. The BioPAX community standard for pathway data sharing Nat. Biotechnol. 28 2010 935 942
28. T.M. Thomson et al. Quantitative assessment of biological impact using transcriptomic data and mechanistic network models Toxicol. Appl. Pharmacol. 2013
29. F. Martin et al. Assessment of network perturbation amplitude by applying high-throughput data to causal biological networks BMC Syst. Biol. 6 2012 54
30. W.K. Schlage et al. A computable cellular stress network model for non-diseased pulmonary and cardiovascular tissue BMC Syst. Biol. 5 2011 168
31. S. Gebel et al. Construction of a computable network model for DNA damage, autophagy, cell death, and senescence Bioinform. Biol. Insights 7 2013 97 117
32. N.L. Catlett et al. Reverse causal reasoning: applying qualitative causal knowledge to the interpretation of high-throughput data BMC Bioinformatics 2013
33. M. Kanehisa et al. KEGG for integration and interpretation of large-scale molecular data sets Nucleic Acids Res. 40 2012 D109 D114
34. M.E. Smoot et al. Cytoscape 2.8: new features for data integration and network visualization Bioinformatics 27 2011 431 432
35. B. Burchell et al. Substrate specificity of human hepatic Udp-glucuronosyltransferases Methods Enzymol. 400 2005 46 57
36. F.P. Guengerich Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity Chem. Res. Toxicol. 14 2001 611 650
37. G.P. Pfeifer et al. Tobacco smoke carcinogens, DNA damage and p 53 mutations in smoking-associated cancers Oncogene 21 2002 7435 7451
38. J.H. Kim et al. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1 Carcinogenesis 19 1998 1847 1853
39. R. Piipari et al. Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers Int. J. Cancer 86 2000 610 616
40. D.H. Phillips et al. Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells Int. J. Cancer 46 1990 569 575
41. R. Chari et al. Effect of active smoking on the human bronchial epithelium transcriptome BMC Genomics 8 2007 297
42. A. Spira et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome Proc. Natl. Acad. Sci. U. S. A. 101 2004 10143 10148
43. T.R. Sutter et al. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2 J. Biol. Chem. 269 1994 13092 13099
44. T. Shimada et al. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1 Cancer Res. 56 1996 2979 2984
45. S. Fukumoto et al. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas Clin. Cancer Res. 11 2005 1776 1785
46. R. Piipari et al. Glutathione S-transferases and aromatic DNA adducts in smokers' bronchoalveolar macrophages Lung Cancer 39 2003 265 272
47. J. Beane et al. Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq Cancer Prev. Res. (Phila.) 4 2011 803 817
48. S. Gebel et al. Gene expression profiling in respiratory tissues from rats exposed to mainstream cigarette smoke Carcinogenesis 25 2004 169 178
49. S. Gebel et al. The kinetics of transcriptomic changes induced by cigarette smoke in rat lungs reveals a specific program of defense, inflammation, and circadian clock gene expression Toxicol. Sci. 93 2006 422 431
50. Martin, F. (2013) Systems and methods for network-based biological activity assessment. WO Patent 2,013,034,300
51. J. Beane et al. Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression Genome Biol. 8 2007 R201
52. F. Schembri et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium Proc. Natl. Acad. Sci. 106 2009 2319 2324
53. Y. Strulovici-Barel et al. Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke Am. J. Respir. Crit. Care Med. 182 2010 1524
54. Y. Bosse et al. Molecular signature of smoking in human lung tissues Cancer Res. 72 2012 3753 3763
55. P.H. Karp et al. An in vitro model of differentiated human airway epithelia Methods Mol. Biol. 188 2002 115 137
56. H. Maunders et al. Human bronchial epithelial cell transcriptome: gene expression changes following acute exposure to whole cigarette smoke in vitro Am. J. Physiol. Lung Cell. Mol. Physiol. 292 2007 L1248 L1256
57. A.A. Pezzulo et al. The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia Am. J. Physiol. Lung Cell. Mol. Physiol. 300 2011 L25 L31
58. C. Mathis et al. Human bronchial epithelial cells exposed in vitro to cigarette smoke at the air-liquid interface resemble bronchial epithelium from human smokers Am. J. Physiol. Lung Cell. Mol. Physiol. 304 2013 L489 L503
59. C.D. Mathers, and D. Loncar Projections of global mortality and burden of disease from 2002 to 2030 PLoS Med. 3 2006 e442
60. A. Churg et al. Mechanisms of cigarette smoke-induced COPD: insights from animal models Am. J. Physiol. Lung Cell. Mol. Physiol. 294 2008 L612 L631
61. R.A. Pauwels, and K.F. Rabe Burden and clinical features of chronic obstructive pulmonary disease (COPD) Lancet 364 2004 613 620
62. K.F. Rabe et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am. J. Respir. Crit. Care Med. 176 2007 532 555
63. Hoeng, J. et al. (2012) Systems and methods for quantifying the impact of biological perturbations. WO Patent 2,012,168,481
64. E.L. Beckett et al. A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis J. Allergy Clin. Immunol. 131 2013 752 762
65. J.W. Westra et al. A modular cell-type focused inflammatory process network model for non-diseased pulmonary tissue Bioinform. Biol. Insights 7 2013 167 192
66. W. Stinn et al. Lung inflammatory effects, tumorigenesis, and emphysema development in a long-term inhalation study with cigarette mainstream smoke in mice Toxicol. Sci. 131 2013 596 611
67. J.S. Park et al. Construction of a computable network model of tissue repair and angiogenesis in the lung J. Clinic. Toxicol. 2013 2013 S12 S22
68. H. Wang et al. An omics strategy for discovering pulmonary biomarkers potentially relevant to the evaluation of tobacco products Biomarkers 6 2012 849 860
69. P. Meyer et al. Verification of systems biology research in the age of collaborative competition Nat. Biotechnol. 29 2011 811 815
70. P. Meyer et al. Industrial methodology for process verification in research (IMPROVER): toward systems biology verification Bioinformatics 28 2012 1193 1201
71. S. Boue et al. Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice Atherosclerosis 225 2012 328 334
72. W. Stinn et al. Towards the validation of a lung tumorigenesis model with mainstream cigarette smoke inhalation using the A/J mouse Toxicology 305 2013 49 64
73. The R Development Core Team R: A Language and Environment for Statistical Computing 2008 V. R. Foundation for Statistical Computing Austria
74. R. Gentleman et al. Bioinformatics and Computational Biology Solutions Using R and Bioconductor 2005 Springer Science & Business Media New York
75. R.C. Gentleman et al. Bioconductor: open software development for computational biology and bioinformatics Genome Biol. 5 2004 R80
76. R.A. Irizarry et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 4 2003 249 264
77. J.W. Westra et al. Construction of a computable cell proliferation network focused on non-diseased lung cells BMC Syst. Biol. 5 2011 105